Corrigendum to “Agomelatine improves streptozotocin-induced diabetic nephropathy through melatonin receptors/SIRT1 signaling pathway” [Int. Immunopharmacol. 115 (2023) 109646]
International Immunopharmacology · 2026-09 · 185 · 116815
DOI: 10.1016/j.intimp.2026.116815 ↗Kurz gefasst
Korrektur in der Zeitschrift International Immunopharmacology, 2026-09. Verfasst von Nevertyty M Mahmoud und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt. Electronic address: NMMahmud@medicine.zu.edu.eg.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Clinical Pharmacology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt. Electronic address: NMMahmud@medicine.zu.edu.eg.
- Pharmacology and Toxicology Department, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt. Electronic address: shaimaa.elshazly@su.edu.eg.
- Pharmacology and Toxicology Department, Faculty of Pharmacy and Pharmaceutical Industries, Sinai University, El-Arish, Egypt. Electronic address: arwa.ahmed@su.edu.eg.
- Pharmacology and Toxicology Department, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt. Electronic address: solimane@zu.edu.eg.
Zitieren
APA
Mahmoud, N. M., Elshazly, S. M., Hassan, A. A., & Soliman, E. (2026). Corrigendum to “Agomelatine improves streptozotocin-induced diabetic nephropathy through melatonin receptors/SIRT1 signaling pathway” [Int. Immunopharmacol. 115 (2023) 109646]. International Immunopharmacology, 185, 116815. https://doi.org/10.1016/j.intimp.2026.116815
Vancouver
Mahmoud NM, Elshazly SM, Hassan AA, Soliman E. Corrigendum to “Agomelatine improves streptozotocin-induced diabetic nephropathy through melatonin receptors/SIRT1 signaling pathway” [Int. Immunopharmacol. 115 (2023) 109646]. International Immunopharmacology. 2026;185:116815. doi:10.1016/j.intimp.2026.116815
BibTeX
@article{Mahmoud2026,
author = {Mahmoud, Nevertyty M and Elshazly, Shimaa M and Hassan, Arwa A and Soliman, Eman},
title = {Corrigendum to “Agomelatine improves streptozotocin-induced diabetic nephropathy through melatonin receptors/SIRT1 signaling pathway” [Int. Immunopharmacol. 115 (2023) 109646]},
journal = {International Immunopharmacology},
year = {2026},
volume = {185},
pages = {116815},
doi = {10.1016/j.intimp.2026.116815}
}
EUVIMED